This important book also offers an overview of the changes in legislation that have reflected growing concern regarding the evolution in the way that the substance has been formulated. Discussed are the illicit use of amphetamine type substances and the associated dangers and concerns with the treatment of attention deficit hyperactivity disorder and the drug's use in the suppression of appetite.
Diane Riley is the Director of the Harm Reduction Network, a policy analyst with the Canadian Foundation for Drug Policy and the International Harm Reduction Association, and a Professor in the Faculty of Medicine at the University of Toronto, Canada.